Home >> ALL ISSUES >> 2018 Issues >> Newsbytes

Newsbytes

image_pdfCreate PDF

Nebraska informaticians mine and translate genomic data

September 2018—More than five years have elapsed since clinicians at the University of Nebraska Medical Center approached the institution’s informatics department with a problem. They wanted to more easily access structured genomic data stored in the EHR system for the diagnosis of cancer patients.

UNMC’s Scott Campbell, PhD, director of informatics for the public health and pathology laboratories, and James Campbell, MD, professor of internal medicine, pondered the problem and set to work preparing a solution for coding and mining molecular pathology test results.

The complex genomic data created from sequencing pipelines are not represented in a form that is readable in EHRs, says Dr. Scott Campbell. Furthermore, raw genomic data are difficult to translate into actionable information that clinicians can use at the point of care. So, together, the doctors engineered a bioinformatic process to extract discrete molecular data—or “computable anatomic and molecular pathology facts,” as Dr. James Campbell refers to them—from sequencing pipelines and convert them into a format that EHRs and clinical data warehouses can readily consume and that conforms to standards that EHRs support, so they can be disseminated broadly.

Because both men had experience with SNOMED CT (Systematized Nomenclature of Medicine Clinical Terms) and LOINC (Logical Observation Identifiers Names and Codes), with Dr. James Campbell having devoted more than three decades to developing SNOMED, it seemed natural to use these standard terminologies for their project. The issue, however, was that neither terminology could properly describe the molecular data, so the doctors worked with SNOMED International to develop extensions to the relevant codes and code definitions. “We authored those term extensions in conjunction with advice from our colleagues in the CAP Informatics Committee and with other molecular pathologists abroad as we tried to develop consensus on how to represent these data,” Dr. Scott Campbell explains.

After receiving input from the CAP Informatics Committee, Drs. Scott Campbell and James Campbell created a question in SNOMED CT to address genetic variance at a particular gene locus. The answer for the variance that was observed was rendered in Human Genome Variance Society nomenclature. “We took that and embedded it into our molecular pathology software system, and our reports, upon sign-out, transfer that data, as HL7 messages, to our NebraskaCARES biobank software, and we also get a fully written report in PDF,” says Dr. Scott Campbell. “The HL7 format is something that can be readily accepted by our Epic EHR,” he adds, “and we are ready to begin steps toward implementation.”

The PDF format, Dr. Scott Campbell points out, “is very helpful the first time the doctor reads the report. However, the PDF report gets filed away in our EHR system and is no longer easily found and the data in it is not computable.” The computable data transferred to the EHR, on the other hand, can be presented as a flowsheet report that follows the patient longitudinally. That report can be presented in the EHR “almost as you would present a CBC,” he says. “So when the physician is looking for a particular molecular result or is trying to determine if a certain test was or was not done yet, it’s much easier to find in a flowsheet than it is to find looking through PDF documents. When a patient is no longer responding to a particular therapy, for example, this information is usually sought. It also enables physicians to surveil the patient.”

The CAP recommends that molecular labs be able to surveil their results and observations to recall or identify patients with a particular variance, Dr. Scott Campbell continues. “As it relates to lab quality, this allows laboratorians to look at the molecular data and compare it to what they believe should be present or should be the norm for the lab. Are we over- or undercalling a particular number of variances that we would expect because there is a change in our environment? Is that because there is a change in our pipeline—in its performance? Has something fallen out of calibration or has the process altered? It’s definitely something that the laboratorian can use to determine or assess the performance of their equipment if they see abnormal trends in the results they produce.”

All of these efforts feed into the goal of having “an intelligent EHR that will support cancer precision medicine,” says Dr. James Campbell. “People are very excited that this is possible,” Dr. Scott Campbell adds.

UNMC has published the terminology for the methodology “and it is currently being promoted into international standards,” Dr. James Campbell notes. The terminology is accessible through the University of Nebraska website (www.unmc.edu/​pathology/​informatics/tdc.html) to those with a SNOMED CT license through the National Library of Medicine. Vendors that license the methodology can integrate the open-source terminology with their products.

The SNOMED community has reacted enthusiastically to this offering, says Dr. Scott Campbell, and feedback from molecular pathologists, oncologists, and other clinicians, as well as researchers, will help refine it. “It’s certainly not a perfect system,” he adds. “It’s revolutionary, but that doesn’t mean it’s not going to have hurdles.” —Iulia Filip

Mount Sinai center addresses blockchain in health care

The Icahn School of Medicine at Mount Sinai has established the Center for Biomedical Blockchain Research. “The ambitious venture—the first of its kind at any academic medical center—will place Mount Sinai on the cutting edge of research that uses the technology, a distributed, decentralized secure database system originally developed for Bitcoin, to solve problems in health care and medical science,” according to a Mount Sinai press release.

The center will operate as part of Mount Sinai’s Institute for Next Generation Healthcare, which was founded in 2016 to advance such technologies and disciplines as artificial intelligence, robotics, genomic sequencing, wearable devices and sensors, and cloud computing.

“Our aim is to understand whether blockchain and associated technologies can be used to solve open problems in health care and biomedical research,” says Noah Zimmerman, PhD, director of the institute’s health data and design innovation center.

CAP TODAY
X